Dis-Chem Pharmacies (DCPJ.J)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|67||2016||Independent Non-Executive Chairman of the Board|
|66||2005||Chief Executive Officer, Executive Director|
|32||2012||Chief Financial Officer, Executive Director|
|64||2005||Managing Director, Executive Director|
- South Africa's Dis-Chem raises $82 million in accelerated bookbuild
- BRIEF-Dis-Chem Pharmacies Says Selling Shareholders Raised R1.12 bln via Bookbuild
- BRIEF-Dis-Chem Pharmacies Announcement In Relation To Accelerated Bookbuild
- BRIEF-Dis-Chem Pharmacies reports HY adj HEPS of 46.8 cents/share
- UPDATE 1-South Africa's rand on the mend as investors buy cheaper levels